Clinical recommendations: conspirasion in adults


DOI: https://dx.doi.org/10.18565/therapy.2020.4.77-101

Developed by Russian Scientific Medical Society of Internal Medicine (RSMSIM) and Scientific Society of Gastroenterologists of Russia (SSGR) in 2019.
Keywords: chronicle constipation, diagnosis of constipation, non-drug treatment of constipation, pharmacotherapy of constipation
Read entire article

Literature


  1. Drossman D.A. Hasler W.L. Rome IV – functional GI disorders: disorders of gut-brain interaction. Gastroenterology. 2016; 150(6): 1257–61. doi: 10.1053/j.gastro.2016.03.035.

  2. Парфенов А.И., Индейкина Л.Х., Беляева А.А. с соавт. Хронический запор. Методические рекомендации. Москва. 2016; 54 с. [Parfenov A.I., Indeykina L.Kh., Belyaeva A.A. et al. Chronic constipation. Guidelines. M. 2016; 54 p. (In Russ.)].

  3. Bharucha A.E., Dorn S.D., Lembo A., Pressman A. American Gastroenterological Association medical position statement on constipation. Gastroenterology. 2013; 144(1): 211–17. doi: 10.1053/j.gastro.2012.10.029.

  4. Dukas L., Willett W.C., Giovannucci E.L. Association between physical activity, fiber intake, and other lifestyle variables and constipation in a study of women. Am J Gastroenterol. 2003; 98: 1790–96. doi: 10.1111/j.1572-0241.2003.07591.x.

  5. Chu H., Zhong L., Li H. et al. Epidemiology characteristics of constipation for general population, pediatric population, and elderly population in China. Gastroenterol Res Pract. 2014; 2014: 532734. doi: 10.1155/2014/532734.

  6. Vazquez Roque M., Bouras E.P. Epidemiology and management of chronic constipation in elderly patients. Clin Interv Aging. 2015; 10: 919–30. doi: 10.2147/CIA.S54304.

  7. Enck P., Leinert J., Smid M. et al. Prevalence of constipation in the German population – a representative survey (GECCO). United European Gastroenterol J. 2016; 4(3): 429–37. doi: 10.1177/2050640615603009.

  8. Wald A., Scarpignato C., Mueller-Lissner S. et al. A multinational survey of prevalence and patterns of laxative use among adults with self-defined constipation. Aliment Pharmacol Ther. 2008; 28(7): 917–30. doi: 10.1111/j.1365-2036.2008.03806.x.

  9. Лазебник Л.Б., Прилепская С.И., Барышникова Е.Н. с соавт. Распространенность и факторы риска запоров у взрослого населения Москвы (по данным популяционного исследования «МУЗА». Экспериментальная и клиническая гастроэнтерология. 2011; 3: 68–73. [Lazebnik L.B., Prilepskaya S.I., Baryshnikova E.N. et al. Prevalence and risk factors for constipation in the adult population of Moscow (according to population study MUZA). Eksperimental'naya i klinicheskaya gastroenterologiya. 2011; 3: 68–73 (In Russ.)].

  10. Bharucha A.E. Constipation. Best Pract Res Clin Gastroenterol. 2007; 21(4):709–31. doi: 10.1016/j.bpg.2007.07.001.

  11. Bassotti G., Bellini M., Pucciani F. et al. Italian Constipation Study Group. An extended assessment of bowel habits in a general population. World J Gastroenterol. 2004; 10: 713–16. doi: 10.3748/wjg.v10.i5.713.

  12. Branch R.L., Butt T.F. Drug-induced constipation. Adv Drug Reaction Bull. 2009; 257: 987–90.

  13. Tack J., Muller-Lissner S., Stanghellini V. et al. Diagnosis and treatment of chronic constipation – a European perspective. Neurogastroenterol Motil. 2011; 23(8):697–710. doi: 10.1111/j.1365-2982.2011.01709.x.

  14. Enck P., Leinert J., Menno Smid M. et al. Somatic comorbidity in chronic constipation: more data from the GECCO study. United European Gastroenterol J. 2016; 4(1): 142–51. doi: 10.1177/2050640614558476.

  15. Choung R.S, Rey E., Locke III G.R. et al. Chronic constipation and co-morbidities: A prospective population-based nested case-control study. United European Gastroenterology Journal. 2016; 4(1): 142–51. doi: 10.1177/2050640614558476.

  16. Talley N.J. How to do and interpret a rectal examination in gastroenterology. Am J Gastroenterol. 2008; 103(4): 820–22. doi: 10.1111/j.1572-0241.2008.01832.x.

  17. Jamshed N., Lee Z.-E., Olden K.W. Diagnostic approach to chronic constipation in adults. Am Fam Physician. 2011; 84(3): 299–306.

  18. Стандарт медицинской помощи больным с болезнью Гиршпрунга (при оказании специализированной помощи). Утвержден Приказом Миздравсоцразвития России от 29 мая 2007 г. № 362. [Medical care for patients with Hirschsprung’s disease (in the provision of specialized care). Approved by Order of the Ministry of Healthcare of Russia of May 29, 2007, No. 362 (In Russ.)].

  19. Стандарт медицинской помощи больным с болезнью Гиршпрунга. Утвержден Приказом Миздравсоцразвития России от 9 февраля 2006 года № 73. [Medical care for patients with Hirschsprung’s disease. Approved by Order of the Ministry of Healthcare of Russia of February 9, 2006, No. 73 (In Russ.)].

  20. Стандарт медицинской помощи больным мегаколоном. Утвержден Приказом Миздравсоцразвития России от 9 февраля 2006 года № 67. [Medical care for patients with megacolon. Approved by Order of the Ministry of Healthcare of Russia of February 9, 2006, No. 67 (In Russ.)].

  21. Gao R., Tao Y., Zhou C. et al. Exercise therapy in patients with constipation: a systematic review and meta-analysis of randomized controlled trials. Scand J Gastroenterol. 2019; 54(2): 169–77. doi: 10.1080/00365521.2019.1568544.

  22. Walter S.C., Correa Neto I.J.F., Pinto R.A. et al. Diagnosis and treatment of constipation: a clinical update based on the Rome IV criteria. J Coloproctol (Rio J). 2018; 38(2): 137–44.

  23. Lee-Robichaud H., Thomas K., Morgan J., Nelson R.L. Lactulose versus polyethylene glycol for chronic constipation. Cochrane Database Syst Rev. 2010; 7: CD007570. doi: 10.1002/14651858.CD007570.pub2.

  24. Fleming V., Wade W.E. A review of laxative therapies for treatment of chronic constipation in older adults. Am J Geriatr Pharmacother. 2010; 8(6): 514–50. doi: 10.1016/S1543-5946(10)80003-0.

  25. Marlett J., Kajs T., Fischer M. An unfermented gel component of psyllium seed husk promotes laxation as a lubricant in humans. Am J Clin Nutr. 2000; 72: 784–89. doi: 10.1093/ajcn/72.3.784.

  26. Ford A.C., Suares N.C. Effect of laxatives and pharmacological therapies in chronic idiopathic constipation: systematic review and meta-analysis. Gut. 2011; 60: 209–18. doi: 10.1136/gut.2010.227132.

  27. Anti M., Pignataro G., Armuzzi A. et al. Water supplementation enhances the effect of high-fiber diet on stool frequency and laxative consumption in adult patients with functional constipation. Hepatogastroenterology. 1998; 45:727–32.

  28. Lee-Robichaud H., Thomas K., Morgan J., Nelson R.L. Lactulose versus polyethylene glycol for chronic constipation. Cochrane Database Syst Rev. 2010; 7: CD007570. doi: 10.1002/14651858.CD007570.pub2.

  29. Suares N.C., Ford A.C. Systematic review: the effects of fibre in the management of chronic idiopathic constipation. Aliment Pharmacol Ther. 2011; 33: 895–90. doi: 10.1111/j.1365-2036.2011.04602.x.

  30. Ford A., Moayyedi P., Lacy B.E. et al. American College of Gastroenterology monograph on the management of irritable bowel syndrome and chronic idiopathic constipation. Am J Gastroenterol. 2014;109 Suppl 1: S2–26; quiz S27. doi: 10.1038/ajg.2014.187.

  31. Chmielewska A., Szajewska H. Systematic review of randomized controlled trials: probiotics for functional constipation. World J Gastroenterol. 2010; 16(1): 69–75. doi: 10.3748/wjg.v16.i1.69.

  32. Ojetti V., Ianiro G., Tortora A. et al. The effect of Lactobacillus reuteri supplementation in adults with chronic functional constipation: a randomized, double-blind, placebo-controlled trial. J Gastrointestin Liver Dis. 2014; 23: 387–91. doi: 10.15403/jgld.2014.1121.234.elr.

  33. Quigley Eamonn M.M. Prucalopride: safety, efficacy and potential applications. Ther Adv Gastroenterol. 2012; 5(1) 23–30. doi: 10.1177/1756283X11423706.

  34. Зароднюк И.В. Рентгенологическая дефекография в обследовании колопроктологических больных. Радиология – практика. 2004; 2: 26–30. [Zarodnyuk I.V. X-ray defecography in the examination of coloproctological patients. Radiologiya – praktika. 2004; 2: 26–30 (In Russ.)].

  35. Левин М.Д., Дегтярев Ю.Г., Аверин В.И. с соавт. Стандартизация рентгенологического исследования толстой кишки и аноректальной зоны. Новости хирургии. 2013; 4: 90–98. [Levin M.D., Degtyarev Yu.G., Averin V.I. et al. Standardization of X-ray examination of the colon and anorectal zone. Novosti khirurgii. 2013; 4: 90–98 (In Russ.)]. doi: 10.18484/2305-0047.2013.4.90.

  36. Paquette I.M., Madhulika V., Charles T. et al. The American Society of Colon and Rectal Surgeons’ clinical practice guideline for the evaluation and management of constipation. Dis Colon Rectum. 2016; 59(6): 479–92. doi: 10.1097/DCR.0000000000000599.

  37. Southwell B.R., Clarke M.C., Sutcliffe J., Hutson J.M. Colonic transit studies: Normal values for adults and children with comparison of radiological and scintigraphic methods. Pediatr Surg Int. 2009; 25(7): 559–72. doi: 10.1007/s00383-009-2387-x.

  38. Sleisenger M.H., Feldman M., Friedman L.S., Brandt LJ. Sleisenger & Fordtran’s gastrointestinal and liver disease: pathophysiology, diagnosis, management. 8th ed. Philadelphia: Saunders. 2006; pp. 2127–46.

  39. Парфенов А.И. Энтерология. Триада-Х. 2002; 744 с. [Parfenov A.I. Enterology. Triada-X. 2002; 744 с. (In Russ.)].

  40. Шемеровский К.А. Хронопатологические аспекты моторно-эвакуаторной функции пищеварительного тракта. Глава 19. Хронобиология и хрономедицина: руководство. Под ред. С.И. Рапопорта, В.А. Фролова, Л.Г. Хетагуровой. М.: Медицинское информационное агентство. 2012; 480 с. [Shemerovsky K.A. Chronopathological aspects of the motor-evacuation function of the digestive tract. Chapter 19. Chronobiology and chronomedicine: A guide. Ed. by Rapoport S.I., Frolov V.A., Khetagurova L.G. M.: Meditsinskoe informatsionnoe agentstvo. 2012; 480 p. (In Russ.)].

  41. Sleisenger M.H., Feldman M., Friedman L.S., Brandt LJ. Sleisenger & Fordtran’s gastrointestinal and liver disease: pathophysiology, diagnosis, management. 8th ed. Philadelphia: Saunders. 2006; pp. 2127–46.

  42. Phillips L.K., Rayner C.K., Jones K.L., Horowitz M. An update on autonomic neuropathy affecting the gastrointestinal tract. Curr Diab Rep. 2006; 6: 417–23. doi: 10.1007/s11892-006-0073-0.

  43. Forgacs I., Patel V. Diabetes and the gastrointestinal tract. Medicine. 2011; 39: 288–92.

  44. Krishnan B., Babu S., Walker J. et al. Gastrointestinal complications of diabetes mellitus. World J Diabetes. 2013; 4(3): 51–63. doi: 10.4239/wjd.v4.i3.51

  45. Chandrasekharan B., Anitha M., Blatt R. et al. Colonic motor dysfunction in human diabetes is associated with enteric neuronal loss and increased oxidative stress. Neurogastroenterol Motil. 2011; 23(2): 131–38, e26. doi: 10.1111/j.1365-2982.2010.01611.x.

  46. Maisey A. A practical approach to gastrointestinal complications of diabetes. Diabetes Ther. 2016; 7(3): 379–86. doi: 10.1007/s13300-016-0182-y.

  47. Ihana-Sugiyama N., Nagata N., Yamamoto-Honda R. et al. Constipation, hard stools, fecal urgency, and incomplete evacuation, but not diarrhea is associated with diabetes and its related factors. World J Gastroenterol. 2016; 22(11): 3252–60. doi: 10.3748/wjg.v22.i11.3252.

  48. Choung R.S, Rey E., Locke III G.R. et al. Chronic constipation and co-morbidities: A prospective population-based nested case-control study. United European Gastroenterology Journal. 2016; 4(1): 142–51. doi: 10.1177/2050640614558476.

  49. Pustorino S., Foti M., Calipari G. et al. [Thyroid-intestinal Motility Interactions Summary]. Minerva Gastroenterol Dietol. 2004; 50(4): 305–15.

  50. Ebert E.C. The thyroid and the gut. J Clin Gastroenterol. 2010; 44(6): 402–06. doi: 10.1097/MCG.0b013e3181d6bc3e.

  51. Tenore A., Fasano A., Gasparini N. et al. Thyroxine effects on intestinal Cl-HCO3-exchange in hypo- and hyperthyroid rats. J Endocrinol. 1996: 151: 431. doi: 10.1677/joe.0.1510431.

  52. Abbasi A.A., Douglass R.C., Bissel G.W., Chen Y. Myxedema ileus. A form of intestinal pseudo-obstruction. JAMA. 1975; 234(2): 181–83. doi: 10.1001/jama.234.2.181.

  53. Koksal A.R., Ergun M., Boga S. et al. Increased prevalence of colorectal polyp in acromegaly patients: a case-control study. Diagn Ther Endosc. 2014; 2014: 152049. doi: 10.1155/2014/152049.

  54. Rokkas T., Pistiolas D., Sechopoulos P. et al. Risk of colorectal neoplasm in patients with acromegaly: a meta‑analysis. World J Gastroenterol. 2008; 14(22): 3484–89. doi: 10.3748/wjg.14.3484.

  55. Wassenaar M.J., Cazemier M., Biermasz N.R. et al. Acromegaly is associated with an increased prevalence of colonic diverticula: a case-control study. J Clin Endocrinol Metab. 2010; 95(5): 2073–79. doi: 10.1210/jc.2009-1714.

  56. Renehan A.G., Painter J.E., Bell G.D. et al. Determination of large bowel length and loop complexity in patients with acromegaly undergoing screening colonoscopy. Clin Endocrinol (Oxf). 2005; 62: 323–30. doi: 10.1111/j.1365-2265.2005.02217.x.

  57. Zhao L., Liu J.-M., He X.-Y. et al. The changing clinical patterns of primary hyperparathyroidism in Chinese patients: data from 2000 to 2010 in a single clinical center. J Clin Endocrinol Metab. 2013; 98(2): 721–28. doi: 10.1210/jc.2012-2914..

  58. Bargren A.E., Repplinger D., Chen H., Sippel R.S. Can biochemical abnormalities predict symptomatology in patients with primary hyperparathyroidism? J. Am. Coll. Surg. 2011; 213(3): 410–14. doi: 10.1016/j.jamcollsurg.2011.06.401.

  59. de Oliveira S.C., Pinto-Neto A.M., Goes J.R. et al. [Prevalence and factors associated with intestinal constipation in postmenopausal women]. Arq Gastroenterol. 2005; 42(1): 24–29. doi: 10.1590/s0004-28032005000100007.

  60. Oh J.-E., Kim Y.-W., Park S.-Y., Kim J.-Y. Estrogen rather than progesterone cause constipation in both female and male mice. Korean J Physiol Pharmacol. 2013; 17(5): 423–26. doi: 10.4196/kjpp.2013.17.5.423.

  61. Bassotti G., Villanacci V., Bellomi A. et al. An assessment of enteric nervous system and estroprogestinic receptors in obstructed defecation associated with rectal intussusception. Neurogastroenterol Motil. 2012; 24(3): e155–61. doi: 10.1111/j.1365-2982.2011.01850.x.

  62. Coggrave M., Norton C., Cody J.D. Management of fecal incontinence and constipation in adults with central neurological diseases. Cochrane Database Syst Rev. 2014; 1: CD002115. doi: 10.1002/14651858.CD002115.pub5.

  63. Jost W.H. Gastrointestinal motility problems in patients with Parkinson’s disease. Effects of antiparkinsonian treatment and guidelines for management. Drugs Aging. 1997; 10: 249–58. doi: 10.2165/00002512-199710040-00002.

  64. Norton C., Chelvanayagam S. Bowel problems and coping strategies in people with multiple sclerosis. Br J Nurs. 2010; 19(4): 220, 221–26. doi: 10.12968/bjon.2010.19.4.46783.

  65. Nusrat S., Gulick E., Levinthal D., Bielefeldt K. Anorectal dysfunction in multiple sclerosis: a systematic review. ISRN Neurol. 2012; 2012: 376023. doi: 10.5402/2012/376023.

  66. Collins P., Rhodes J. Ulcerative colitis: diagnosis and management. BMJ. 2006; 333(7563): 340–43. doi: 10.1136/bmj.333.7563.340.

  67. Fargo M.V., Latimer K.M. Evaluation and management of common anorectal conditions. Am Fam Physician. 2012; 85(6): 624–30.

  68. Salmoirago-Blotcher E., Crawford S., Jackson E. et al. Constipation and risk of cardiovascular disease among postmenopausal women. Am J Med. 2011; 124(8): 714–23. doi:10.1016/j.amjmed.2011.0

  69. Honkura K., Tomata Y., Sugiyama K. et al. Defecation frequency and cardiovascular disease mortality in Japan: The Ohsaki cohort study. Atherosclerosis. 2016; 246: 251–56. doi: 10.1016/j.atherosclerosis.2016.01.007.

  70. Bassotti G. Being constipated: A bad omen for your cardiovascular system? Atherosclerosis. 2016; 245: 240–41. doi: 10.1016/j.atherosclerosis.2015.10.001.

  71. Ma W., Li Y., Heianza Y. et al. Associations of bowel movement frequency with risk of cardiovascular disease and mortality among US women. Sci Rep. 2016; 6: 33005. doi: 10.1038/srep33005.

  72. Markland А., Dunivan G,. Vaughan C. et al. Anal intercourse and fecal incontinence: evidence from the 2009–2010 National Health and Nutrition Examination Survey. Am J Gastroenterol. 2016; 111(2): 269–74. doi: 10.1038/ajg.2015.419.

  73. Locke G.R., Pemberton J.H., Phillips S.F. AGA technical review on constipation: American Gastroenterological Association. Gastroentrology. 2000; 119(6): 1766–78. doi: 10.1053/gast.2000.20392.

  74. Talley N.J., Fleming K.C., Evans J.M. et al. Constipation in an elderly community: a study of prevalence and potential risk factors. Am J Gastroenterol. 1996; 91(1): 19–25.

  75. Talley N.J., Jones M., Nuyts G. et al. Risk factors for chronic constipation based on a general practice sample. Am J Gastroenterol. 2003; 98: 1107–11. doi: 10.1111/j.1572-0241.2003.07465.x.

  76. Клинические рекомендации «Подготовка пациентов к эндоскопическому исследованию толстой кишки». Российское эндоскопическое общество. Москва. 2017; 69 с. [Clinical guidelines «Preparing patients for endoscopic examination of the colon». Russian Endoscopic Society. M. 2017; 69 p. (In Russ.)].

  77. Huffman M., Zackary Unger R., Thatikonda C. et al. Split-dose bowel preparation for colonoscopy and residual gastric fluid volume: an observational study. Gastrointest Endosc. 2010; 72(3): 516–22. doi: 10.1016/j.gie.2010.03.1125.

  78. Mohamed R., Hilsden R.J., Dube C., Rostom A. Split-dose polyethylene glycol is superior to single dose for colonoscopy preparation: results of a randomized controlled trial. Can J Gastroenterol Hepatol. 2016; 2016: 3181459. doi: 10.1155/2016/3181459.

  79. Kilgore T.W., Abdinoor A.A., Szary N.M. et al. Bowel preparation with split-dose polyethylene glycol before colonoscopy: a meta-analysis of randomized controlled trials. Gastrointest Endosc. 2011; 73(6): 1240–45. doi: 10.1016/j.gie.2011.02.007.

  80. Enestvedt B.K., Tofani C., Laine L.A. et al. 4-liter split-dose polyethylene glycol is superior to other bowel preparations, based on systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2012; 10(11): 1225–31. doi: 10.1016/j.cgh.2012.08.029.

  81. Hassan C., East J., Radaelli F. et al. Bowel preparation for colonoscopy: European Society of Gastrointestinal Endoscopy (ESGE) guideline – update 2019. Endoscopy. 2019; 51(8): 775–94. doi: 10.1055/a-0959-0505.

  82. Rex D.K., Di Palma J.A., Rodriguez R. et al. A randomized clinical study comparing reduced-volume oral sulfate solution with standard 4-liter sulfate-free electrolyte lavage solution as preparation for colonoscopy . Gastrointest Endosc. 2010; 72(2): 328–36. doi: 10.1016/j.gie.2010.03.1054.

  83. Kaminski M.F., Thomas-Gibson S., Bugajski M. et al. Performance measures for lower gastrointestinal endoscopy: a European Society of Gastrointestinal Endoscopy (ESGE) Quality Improvement Initiative. Endoscopy. 2017; 49(4): 378–97. doi: 10.1055/s-0043-103411.

  84. Ishiyama Y., Hoshide S., Mizuno H., Kario K. Constipationinduced pressor effects as triggers for cardiovascular events. J Clin Hypertens. 2019; 21(5): 421–25. doi: 10.1111/jch.13489.

  85. Pedrosa Carrasco A.J., Timmermann L., Pedrosa D.J. Management of constipation in patients with Parkinson’s disease. NPJ Parkinson’s Disease. 2018; 4: 6. doi: 10.1038/s41531-018-0042-8.

  86. Yan M., Zhang L.-Y., Sun L.-X. et al. Nephrotoxicity study of total rhubarb anthraquinones on Sprague Dawley rats using DNA microarrays. J Ethnopharmacol. 2006; 107(2): 308–11. doi: 10.1016/j.jep.2006.03.031.

  87. Noureddin S., Mohsen J., Payman A. Effects of psyllium vs. placebo on constipation, weight, glycemia, and lipids: A randomized trial in patients with type 2 diabetes and chronic constipation. Complementary Therapies in Medicine. 2018; 40: 1–7. doi: 10.1016/j.ctim.2018.07.004.

  88. Чернусь Н.П., Ванчакова Н.П., Сивкова С.К. с соавт. Ипидакрин в комбинированных схемах лечения функционального запора. Терапевтический архив. 2018; 12: 48–55. [Chernus N.P., Vanchakova N.P., Sivkova S.K. et al. Ipidacrine in combination therapy regimens of functional constipation. Terapevtichesky arkhiv. 2018; 12: 48–55 (In Russ.)]. DOI: 10.26442/00403660.2018.12.000008.


About the Autors

Leonid B. Lazebnik, MD, professor, professor of the Department of outpatient therapy of A.I. Yevdokimov Moscow State University of Medicine and Dentistry of the Ministry of Healthcare of Russia, President of the Scientific Society of Gastroenterologists of Russia, Vice-President of the Russian Scientific Medical Society of Internal Medicine. Address: 127473, Moscow, 20/1 Delegatskaya Str. Tel.: +7 (985) 920-83-42. Email: leonid.borisl@gmail.com

Back to Content

Бионика Медиа